Skip to main content

Month: January 2023

ZetaDisplay publishes financial update for Q4 2022 and provides guidance for the fiscal year 2023

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933) OR IN OR INTO ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW ZetaDisplay publishes financial update for Q4 2022 and provides guidance for the fiscal year 2023 Stockholm, 13 January 2023 In connection with the ongoing debt refinancing process, ZetaDisplay sets out below an update on its financial performance for Q4 2022 and provides guidance for 2023. Key unaudited consolidated financial information for the three months ended 31 December 2022:Net sales increased by 36.8% y-o-y and amounted to SEK 167.4 (122.4) million, with SaaS revenues experiencing a y-o-y growth...

Continue reading

Proactive news headlines including Jindalee Resources, European Lithium, Alkane Resources and Alchemy Resources

Sydney, Jan. 13, 2023 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Jindalee Resources Ltd (ASX:JRL) has completed a spin-out of Australian battery and precious metal assets, forming Dynamic Metals Ltd (ASX:DYM) with an initial public offering (IPO) drawing $7 million in funding as DYM prepares to list to the ASX. Click here European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has signed a non-binding memorandum of understanding (MoU) with Saudi-based Obeikan Investment Group to build and operate a hydroxide plant under a joint venture (JV) in Saudi Arabia for EUR’s Wolfsberg Lithium Project in Austria. Click here Alkane Resources Ltd (ASX:ALK) is due for an earnings review after the company upgraded its FY 2023 guidance for the...

Continue reading

WISeKey Announces FY 2022 Preliminary Revenues of $25.6 Million, a 15% Increase from FY 2021, Despite the Divestiture of arago

WISeKey Announces FY 2022 Preliminary Revenues of $25.6 Million, a 15% Increase from FY 2021, Despite the Divestiture of arago Semiconductor FY 2022 revenues increased to $23.2 million, or 38% as compared to FY 2021 WISeKey’s strong backlog of $36 million for IoT products stretches into 2024 Geneva, Switzerland, January 13, 2023 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules– WISeKey International Holding Ltd (NASDAQ: WKEY / SIX: WIHN) (“WISeKey” or the “Company”), a leading Swiss cybersecurity, AI and IoT company announced today its preliminary unaudited revenues for the year ended December 31, 2022. Consolidated revenues for FY 2022 were $25.6 million, increasing by 15% as compared to $22.3 million reported for FY 2021. The increase was achieved despite the divestiture of arago and it was mainly due to higher revenues...

Continue reading

SpotLite360 IOT Solutions, Inc. Announces Private Placement

DENVER and VANCOUVER, British Columbia and TORONTO, Jan. 13, 2023 (GLOBE NEWSWIRE) — SPOTLITE360 IOT SOLUTIONS, INC. (“SpotLite360” or the “Company”) (CSE: LITE) (OTC: SPLTF) (Frankfurt: 87A) announces that it is offering up to 5,000,000 units of the Company (the “Offer Units”) at a price of C$0.10 per Offer Unit for gross proceeds of no less than C$350,000 and up to C$500,000. Each Offer Unit consisting of one (1) common share and of one common share purchase warrant, each whole common share purchase warrant being exercisable to purchase an additional common share for a period of two years from closing at a price of C$0.12 (the “Offering”). The Company intends to use the aggregate net proceeds of the Offering for the acquisition of environmental control hardware and the implementation services related to realizing...

Continue reading

Skyward Specialty Announces Pricing of Upsized Initial Public Offering

HOUSTON, Jan. 12, 2023 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc. (“Skyward Specialty” or the “Company”) announced today that it has priced its upsized initial public offering of 8,952,383 shares of its common stock, with 4,750,000 shares being offered by Skyward Specialty and 4,202,383 shares being sold by selling stockholders, at a public offering price of $15.00 per share. The underwriters have a 30-day option to purchase up to an additional 1,342,857 common shares from the selling shareholders at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 18, 2023, subject to customary closing conditions. The shares are expected to begin trading on January 13, 2023 on the Nasdaq Global Select Market under the ticker symbol “SKWD.” Skyward...

Continue reading

Atlas Global Brands Expands International Footprint, Announces Binding LOI for Acquisition of Imports Trading House and Two Pharmacies in Israel

VANCOUVER, BRITISH COLUMBIA, CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, Jan. 12, 2023 (GLOBE NEWSWIRE) —Signed LOI to acquire an Israeli licensed cannabis “Trading House”, to serve as a hub for imports to Israel Signed second LOI to acquire two pharmacies licensed to dispense medical cannabisAtlas Global Brands Inc. (“Atlas Global”) (CSE: ATL), (formerly Silver Phoenix Resources Inc. “Silver Phoenix” CSE: SP), a global cannabis company with expertise across the cannabis value chain, today announced that, through its Israeli subsidiary, signed a binding letter of intent (the “LOI”) at an arm’s length with no finder’s fee, on January 11, 2023, to acquire 51% of the outstanding securities of the following entities (the “Proposed Transaction”):An Israeli licensed cannabis “Trading House”, strategically located in Tel Aviv. If...

Continue reading

Global Star Acquisition Inc. Appoints New Members to Audit Committee and Compensation Committee

MCLEAN, VA, Jan. 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Global Star Acquisition, Inc. (Nasdaq: GLSTU) (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, today announced that the Company appointed Argon Lam Chun Win and Jukka Rannila, the current directors of the Company, as members of the Compensation Committee of the Board (the “Compensation Committee”), and appointed Argon Lam Chun Win as a member of the Audit Committee of the Board (the “Audit Committee”). Argon Lam Chun Win Mr. Lam currently serves as an independent director of the Company since November 15, 2022. Jukka Rannila Mr. Rannila currently serves as an independent director and a member of...

Continue reading

Atlas Salt Announces Institutionally Targeted Strategic Private Placement for Up to $10 Million

Project Map Project MapST. JOHN’S, Newfoundland and Labrador, Jan. 12, 2023 (GLOBE NEWSWIRE) — Atlas Salt (the “Company” or “Atlas” – TSXV: SALT; OTCQB: REMRF), 100% owner of North America’s premier undeveloped high-grade salt project, announces a non-brokered private placement for up to five million units at a price of $2.00 per unit for aggregate gross proceeds of up to $10,000,000 (the “Offering”) targeting strategic institutional investors. Each unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each full warrant will entitle the holder thereof to purchase one common share at a price of $2.40 per share at any time two years from the closing of the Offering. The Offering is scheduled to close on or about January 16, 2023 (the “Closing Date”), or such later date as...

Continue reading

MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatment of Recurrent and Newly Diagnosed Glioblastoma

Preliminary results will be presented at the 20th Annual World Congress of the Society for Brain Mapping and Therapeutics LA JOLLA, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Phase 2 clinical trial evaluating MN-166 (ibudilast) in recurrent and newly diagnosed glioblastoma conducted at Dana-Farber Cancer Institute has completed enrollment. This Phase 1/2 clinical trial was divided into a dose-escalation phase (Part 1) followed by a fixed-dose phase (Part 2). Part 1 evaluated the safety and tolerability of an escalating dose of MN-166 (ibudilast) when given in combination with temozolomide (TMZ) and determined a safe and tolerable dose of MN-166...

Continue reading

Clearfield Sets Fiscal First Quarter 2023 Earnings Call for Thursday, February 2, 2023 at 5:00 p.m. ET

MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) — Clearfield, Inc. (NASDAQ: CLFD), the specialist in fiber management for communications providers, will hold a conference call on Thursday, February 2, 2023 at 5:00 p.m. Eastern time (4:00 p.m. Central time) to discuss its financial results for the fiscal first quarter ended December 31, 2022. Financial results will be issued in a press release and the company’s FieldReport prior to the call, which will be available in the Investor Relations section of the company’s website. Comprised of presentation slides that will be used throughout the call, the FieldReport will provide additional insight into the company’s financial and operational performance. Clearfield’s President and CEO Cheri Beranek and CFO Dan Herzog will host the presentation, followed by a question-and-answer period. Date:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.